{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:32Z","timestamp":1792114052463,"version":"4.4.0"},"reference-count":244,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017964","name":"Tianjin Municipal Health Commission","doi-asserted-by":"publisher","award":["TJWJ2021QN008"],"award-info":[{"award-number":["TJWJ2021QN008"]}],"id":[{"id":"10.13039\/100017964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202603"],"award-info":[{"award-number":["82202603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2022ZD066"],"award-info":[{"award-number":["2022ZD066"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.apsb.2024.12.007","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T02:42:18Z","timestamp":1734144138000},"page":"97-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Recent advances in the bench-to-bedside translation of cancer nanomedicines"],"prefix":"10.1016","volume":"15","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8298-3527","authenticated-orcid":false,"given":"Yinchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-4937","authenticated-orcid":false,"given":"Tony Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.12.007_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2024.12.007_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.apsb.2024.12.007_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.12.007_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.apsb.2021.05.031","article-title":"Symphony of nanomaterials and immunotherapy based on the cancer\u2013immunity cycle","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib6","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.apsb.2023.05.016","article-title":"Light-responsive nanomedicine for cancer immunotherapy","volume":"13","author":"Kang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib7","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib8","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.apsb.2024.05.010","article-title":"Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy","volume":"14","author":"Peng","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib9","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","article-title":"Safety of nanoparticles in medicine","volume":"16","author":"Wolfram","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2024.12.007_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7150\/ntno.74613","article-title":"Nanotechnology advances in the detection and treatment of cancer: an overview","volume":"6","author":"Mosleh-Shirazi","year":"2022","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2024.08.001","article-title":"Future prospects in clinical translation of inorganic nanoparticles","author":"Xu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib12","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","article-title":"Current research trends of nanomedicines","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib13","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1039\/D1CS01148K","article-title":"Minimally invasive nanomedicine: nanotechnology in photo-\/ultrasound-\/radiation-\/magnetism-mediated therapy and imaging","volume":"51","author":"Ouyang","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib14","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41467-022-28744-4","article-title":"Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.12.007_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","author":"van der Meel","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.8263","article-title":"Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics","volume":"4","author":"Shen","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt.3506","article-title":"An injectable nanoparticle generator enhances delivery of cancer therapeutics","volume":"34","author":"Xu","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib18","series-title":"Nanotheranostics for diagnosis and therapy","first-page":"189","article-title":"Progress and prospect of nanocarriers: design, concept, and recent advances","author":"Rauf","year":"2024"},{"key":"10.1016\/j.apsb.2024.12.007_bib19","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1007\/s12649-023-02318-x","article-title":"Green synthesis of zinc oxide nanoparticles using egg white and coriander root waste: characterization and anti-cancer efficacy in hela cells","volume":"15","author":"Saeed","year":"2024","journal-title":"Waste Biomass Valor"},{"key":"10.1016\/j.apsb.2024.12.007_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib21","series-title":"Novel platforms for drug delivery applications","first-page":"289","article-title":"Chapter 13 - bionanocomposites as a new platform for drug delivery systems","author":"Mumtaz","year":"2023"},{"key":"10.1016\/j.apsb.2024.12.007_bib22","series-title":"Novel platforms for drug delivery applications","first-page":"217","article-title":"Chapter 10 - hybrid platforms for drug delivery applications","author":"Rehman","year":"2023"},{"key":"10.1016\/j.apsb.2024.12.007_bib23","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.7150\/thno.42564","article-title":"Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202103836","article-title":"Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy","volume":"9","author":"Peng","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40580-021-00282-7","article-title":"Cancer nanotechnology: current status and perspectives","volume":"8","author":"Kemp","year":"2021","journal-title":"Nano Converg"},{"key":"10.1016\/j.apsb.2024.12.007_bib26","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.apsb.2022.02.023","article-title":"Cell membrane coated-nanoparticles for cancer immunotherapy","volume":"12","author":"Zeng","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib27","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1021\/acsnano.3c02273","article-title":"Stimuli-responsive polymeric nanovaccines toward next-generation immunotherapy","volume":"17","author":"Mao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib28","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/pharmaceutics14040866","article-title":"Emerging nanotherapeutic approaches to overcome drug resistance in cancers with update on clinical trials","volume":"14","author":"Bukhari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib30","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.3390\/cancers13102481","article-title":"Enhancing clinical translation of cancer using nanoinformatics","volume":"13","author":"Soltani","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2024.12.007_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00834-3","article-title":"Green synthesis of metal nanoparticles using microorganisms and their application in the agrifood sector","volume":"19","author":"Bahrulolum","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2024.12.007_bib32","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1039\/D0TB02915G","article-title":"Nanoparticle-mediated tumor vaccines for personalized therapy: preparing tumor antigens in\u00a0vivo or ex\u00a0vivo?","volume":"9","author":"Li","year":"2021","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2024.12.007_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jconrel.2020.10.003","article-title":"Actively targeted nanomedicines for precision cancer therapy: concept, construction, challenges and clinical translation","volume":"329","author":"Gu","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/mp3005885","article-title":"Multifunctional gold nanoparticles for diagnosis and therapy of disease","volume":"10","author":"Mieszawska","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2024.12.007_bib35","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/ma16155354","article-title":"Nanoparticles in cancer diagnosis and treatment","volume":"16","author":"Baranwal","year":"2023","journal-title":"Materials"},{"key":"10.1016\/j.apsb.2024.12.007_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mser.2013.03.001","article-title":"Nanoparticles for improving cancer diagnosis","volume":"74","author":"Chen","year":"2013","journal-title":"Mater Sci Eng R Rep"},{"key":"10.1016\/j.apsb.2024.12.007_bib37","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.7150\/thno.40805","article-title":"Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107321","article-title":"Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration","volume":"26","author":"Wu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2024.12.007_bib39","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/molecules28031283","article-title":"Role of nanomedicine-based therapeutics in the treatment of CNS disorders","volume":"28","author":"Guo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2024.12.007_bib40","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.3390\/cancers13184570","article-title":"Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment","volume":"13","author":"Anjum","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2024.12.007_bib41","first-page":"562","article-title":"A cuttlefish ink nanoparticle-reinforced biopolymer hydrogel with robust adhesive and immunomodulatory features for treating oral ulcers in diabetes","volume":"39","author":"Xiang","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib42","first-page":"2647","article-title":"Polydopamine nanoparticle-dotted food gum hydrogel with excellent antibacterial activity and rapid shape adaptability for accelerated bacteria-infected wound healing","volume":"6","author":"Zeng","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib43","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1016\/j.apsb.2021.11.020","article-title":"Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma","volume":"12","author":"Xue","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib44","article-title":"Advanced technologies for molecular diagnosis of cancer: state of pre-clinical tumor-derived exosome liquid biopsies","volume":"18","author":"Li","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.apsb.2024.12.007_bib45","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.nanolett.0c04753","article-title":"A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy","volume":"21","author":"Niu","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib46","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/nano9040638","article-title":"Lipid-based nanoparticles: application and recent advances in cancer treatment","volume":"9","author":"Garc\u00eda-Pinel","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1634\/theoncologist.2013-0126","article-title":"The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials","volume":"18","author":"Gibson","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.apsb.2024.12.007_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2021.07.018","article-title":"Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma","volume":"337","author":"Sharma","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/pharmaceutics16050668","article-title":"Self-immolative domino dendrimers as anticancer-drug delivery systems: a review","volume":"16","author":"K\u0119dra","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejpb.2017.07.003","article-title":"CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition","volume":"119","author":"Chittasupho","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2024.12.007_bib52","article-title":"Nanoparticle drug delivery systems for synergistic delivery of tumor therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2024.12.007_bib53","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/polym12030580","article-title":"Poly (N-isopropylacrylamide)-based thermoresponsive composite hydrogels for biomedical applications","volume":"12","author":"Xu","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2024.12.007_bib54","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1039\/D2LC00933A","article-title":"Design of functional nanoparticles by microfluidic platforms as advanced drug delivery systems for cancer therapy","volume":"23","author":"Fabozzi","year":"2023","journal-title":"Lab Chip"},{"key":"10.1016\/j.apsb.2024.12.007_bib55","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/polym10090961","article-title":"Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles","volume":"10","author":"Kim","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2024.12.007_bib56","article-title":"Strategies to promote the journey of nanoparticles against biofilm-associated infections","volume":"20","author":"Wang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.apsb.2024.12.007_bib57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib58","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/ijms22041976","article-title":"Prpc aptamer conjugated\u2013gold nanoparticles for targeted delivery of doxorubicin to colorectal cancer cells","volume":"22","author":"Go","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12951-021-00871-y","article-title":"Enhancement of doxorubicin anti-cancer activity by vascular targeting using IsoDGR\/cytokine-coated nanogold","volume":"19","author":"Corti","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2024.12.007_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111239","article-title":"Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency","volume":"116","author":"Kundu","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.apsb.2024.12.007_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2019.02.031","article-title":"Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer","volume":"89","author":"Li","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2024.12.007_bib62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M","article-title":"Controlled release of antibiotics from coated orthopedic implants","volume":"30","author":"Price","year":"1996","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib63","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.2147\/DDDT.S86845","article-title":"Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers","volume":"9","author":"Kim","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib64","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1002\/j.1875-9114.2012.01183.x","article-title":"Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain","volume":"32","author":"Candiotti","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.apsb.2024.12.007_bib65","doi-asserted-by":"crossref","first-page":"390","DOI":"10.20517\/cdr.2023.16","article-title":"Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system","volume":"6","author":"Sun","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.apsb.2024.12.007_bib66","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12951-022-01377-x","article-title":"Multifunctional nanoparticles co-loaded with Adriamycin and MDR-targeting siRNAs for treatment of chemotherapy-resistant esophageal cancer","volume":"20","author":"Zhang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2024.12.007_bib67","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/nano12152672","article-title":"Recent advances in nanoparticle-based co-delivery systems for cancer therapy","volume":"12","author":"Al Bostami","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib68","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.apsb.2020.12.016","article-title":"Recent progress in sono-photodynamic cancer therapy: from developed new sensitizers to nanotechnology-based efficacy-enhancing strategies","volume":"11","author":"Zheng","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01080-3","article-title":"Recent advances in selective photothermal therapy of tumor","volume":"19","author":"Zhao","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2024.12.007_bib70","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1016\/j.apsb.2022.03.010","article-title":"Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer","volume":"12","author":"Jia","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib71","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.apsb.2020.01.004","article-title":"Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development","volume":"10","author":"Sun","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib72","article-title":"Recent advances in nanodrug delivery system for tumor combination treatment based on photothermal therapy","volume":"6","author":"Qin","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1024177","article-title":"Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer","volume":"10","author":"Sun","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.apsb.2024.12.007_bib74","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1039\/D0TB01063D","article-title":"Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer","volume":"8","author":"Sun","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2024.12.007_bib75","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1007\/s12274-022-4096-x","article-title":"NIR-II photothermal therapy for effective tumor eradication enhanced by heterogeneous nanorods with dual catalytic activities","volume":"15","author":"Zhang","year":"2022","journal-title":"Nano Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib76","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/pharmaceutics15092257","article-title":"Recent studies in photodynamic therapy for cancer treatment: from basic research to clinical trials","volume":"15","author":"Kim","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0169-5002(03)00242-3","article-title":"Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung","volume":"42","author":"Kato","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.apsb.2024.12.007_bib78","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS2101","article-title":"A phase 1\/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-guided focused ultrasound in patients with progressive or recurrent glioblastoma (rGBM)","volume":"42","author":"Placantonakis","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib79","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1007\/s00432-022-04418-y","article-title":"Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma","volume":"149","author":"Hadi","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib80","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/nano13233060","article-title":"NanoBubble-mediated oxygenation: elucidating the underlying molecular mechanisms in hypoxia and mitochondrial-related pathologies","volume":"13","author":"Viafara Garcia","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib81","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/pharmaceutics13071009","article-title":"Clinical advances of siRNA-based nanotherapeutics for cancer treatment","volume":"13","author":"Hattab","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib82","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2147\/IJN.S200253","article-title":"Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach","volume":"14","author":"Mahmoodi","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib83","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S2666-5247(22)00087-8","article-title":"CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study","volume":"3","author":"Huang","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.apsb.2024.12.007_bib84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gendis.2023.02.027","article-title":"Clinical applications of the CRISPR\/Cas9 genome-editing system: delivery options and challenges in precision medicine","volume":"11","author":"Khoshandam","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2024.12.007_bib85","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.apsb.2022.09.021","article-title":"Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy","volume":"13","author":"Dong","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib86","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib87","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acsnano.2c09018","article-title":"Evaluation of SARS-CoV-2-specific T-cell activation with a rapid on-chip IGRA","volume":"17","author":"Ning","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib88","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41565-021-00939-8","article-title":"Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma","volume":"16","author":"Ning","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2024.12.007_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117263","article-title":"Nano-scale delivery systems for siRNA delivery in cancer therapy: new era of gene therapy empowered by nanotechnology","volume":"239","author":"Ebrahimi","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib91","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.3390\/molecules27165236","article-title":"Curcumin-based nanoformulations: a promising adjuvant towards cancer treatment","volume":"27","author":"Hafez","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2024.12.007_bib92","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/pharmaceutics15020622","article-title":"mRNA-based therapeutics in cancer treatment","volume":"15","author":"Sun","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713618","article-title":"Targeted therapy for cancers: from ongoing clinical trials to FDA-approved drugs","volume":"24","author":"Choi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2017.10.011","article-title":"Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301\/TOP002 phase III clinical trial","volume":"412","author":"Das","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib95","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.apsb.2021.12.021","article-title":"Emerging vaccine nanotechnology: from defense against infection to sniping cancer","volume":"12","author":"Feng","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib96","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2024.12.007_bib97","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1021\/acsnano.4c00550","article-title":"Modulation of dendritic cell function via nanoparticle-induced cytosolic calcium changes","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib98","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/acsnano.9b01444","article-title":"Use of polymeric nanoparticle platform targeting the liver to induce Treg-mediated antigen-specific immune tolerance in a pulmonary allergen sensitization model","volume":"13","author":"Liu","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib99","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.3390\/ijms22168884","article-title":"PLGA\/PLA-based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein\/peptide delivery","volume":"22","author":"Butreddy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib100","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1021\/acs.nanolett.1c03004","article-title":"Personalized nanovaccine coated with calcinetin-expressed cancer cell membrane antigen for cancer immunotherapy","volume":"21","author":"Xiong","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib101","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3390\/vaccines3030662","article-title":"Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy","volume":"3","author":"Fan","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.apsb.2024.12.007_bib102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.copbio.2020.06.015","article-title":"Engineering nanoparticulate vaccines for enhancing antigen cross-presentation","volume":"66","author":"Du","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121794","article-title":"A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy","volume":"289","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib104","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.nanolett.0c04783","article-title":"Engineering nanoscale artificial antigen-presenting cells by metabolic dendritic cell labeling to potentiate cancer immunotherapy","volume":"21","author":"Xiao","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-020-2537-9","article-title":"An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma","volume":"585","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.12.007_bib106","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/s41591-021-01544-x","article-title":"A phase 1\/2 trial of an immune-modulatory vaccine against Ido\/PD-L1 in combination with nivolumab in metastatic melanoma","volume":"27","author":"Kjeldsen","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib107","doi-asserted-by":"crossref","first-page":"LBA9503","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA9503","article-title":"Distant metastasis-free survival results from the randomized, phase 2 mRNA-4157-P201\/KEYNOTE-942 trial","volume":"41","author":"Khattak","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib108","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib109","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.12.007_bib110","first-page":"576","article-title":"Nanoparticle cancer vaccines: design considerations and recent advances","volume":"15","author":"Liu","year":"2020","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib111","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1038\/d41591-023-00072-0","article-title":"Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial","volume":"29","author":"Carvalho","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib112","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/cancers12041049","article-title":"Nanoparticles to improve the efficacy of peptide-based cancer vaccines","volume":"12","author":"Tornesello","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2024.12.007_bib113","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib114","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1021\/acs.nanolett.9b02501","article-title":"NanoRNP overcomes tumor heterogeneity in cancer treatment","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102509","article-title":"Recent advances in active targeting of nanomaterials for anticancer drug delivery","volume":"296","author":"Dutta","year":"2021","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib116","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1021\/acsami.1c20416","article-title":"A nanoarchitectonic approach enables triple modal synergistic therapies to enhance antitumor effects","volume":"14","author":"Mo","year":"2022","journal-title":"ACS Appl Mater Inter"},{"key":"10.1016\/j.apsb.2024.12.007_bib117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2021.07.012","article-title":"Pilot-scale production of expansile nanoparticles: practical methods for clinical scale-up","volume":"337","author":"Colby","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib118","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.drudis.2018.01.047","article-title":"Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities","volume":"23","author":"Agrahari","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.12.007_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007856","article-title":"Microfluidic multi-scale homogeneous mixing with uniform residence time distribution for rapid production of various metal core\u2013shell nanoparticles","volume":"31","author":"Shin","year":"2021","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib122","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.2174\/0929867328666210406115529","article-title":"Regulatory considerations, challenges and risk-based approach in nanomedicine development","volume":"28","author":"Cs\u00f3ka","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2024.12.007_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJN.S288236","article-title":"Engineered nanomaterials: the challenges and opportunities for nanomedicines","volume":"16","author":"Albalawi","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib124","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/ijms24032008","article-title":"Nanomaterials and their impact on the immune system","volume":"24","author":"Aljabali","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib125","article-title":"In\u00a0vivo quantification of nanoparticle association with immune cell subsets in blood","volume":"10","author":"Ong","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib126","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.apsb.2019.01.006","article-title":"Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy","volume":"9","author":"Gao","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib127","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.apsb.2024.03.023","article-title":"Nanoparticle drug delivery system for the treatment of brain tumors: breaching the blood\u2013brain barrier","volume":"14","author":"Tang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib128","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.drudis.2021.04.008","article-title":"Recent advances in nano delivery systems for blood\u2012brain barrier (BBB) penetration and targeting of brain tumors","volume":"26","author":"Reddy","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pharmaceutics12010072","article-title":"PLGA-PEG-ANG-2 nanoparticles for blood\u2013brain barrier crossing: proof-of-concept study","volume":"12","author":"Hoyos-Ceballos","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jconrel.2020.09.042","article-title":"Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in\u00a0vivo brain bioavailability","volume":"328","author":"Rabanel","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib131","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood\u2013brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib132","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood\u2013brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2024.12.007_bib133","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1021\/acsami.1c00347","article-title":"Targeted regulation of blood\u2013brain barrier for enhanced therapeutic efficiency of hypoxia-modifier nanoparticles and immune checkpoint blockade antibodies for glioblastoma","volume":"13","author":"Meng","year":"2021","journal-title":"ACS Appl Mater Inter"},{"key":"10.1016\/j.apsb.2024.12.007_bib134","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acsnano.6b02326","article-title":"Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration","volume":"10","author":"Li","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib135","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/polym14132601","article-title":"Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect","volume":"14","author":"Ejigah","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2024.12.007_bib136","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib138","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","article-title":"The use of alternative strategies for enhanced nanoparticle delivery to solid tumors","volume":"121","author":"Izci","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib139","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/pharmaceutics13010024","article-title":"Progress of cancer nanotechnology as diagnostics, therapeutics, and theranostics nanomedicine: preclinical promise and translational challenges","volume":"13","author":"Alshehri","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.apsb.2020.10.009","article-title":"GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy","volume":"10","author":"Lin","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib141","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib142","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1039\/D1BM01127H","article-title":"Tumor microenvironment and nanotherapeutics: intruding the tumor fort","volume":"9","author":"Kiran","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib143","article-title":"Light-controlled nanosystem with size-flexibility improves targeted retention for tumor suppression","volume":"31","author":"Luo","year":"2021","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib144","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1039\/D1NR03387E","article-title":"Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment","volume":"13","author":"Li","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2024.12.007_bib145","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/cancers12123630","article-title":"Silencing of VEGFR2 by RGD-modified lipid nanoparticles enhanced the efficacy of anti-PD-1 antibody by accelerating vascular normalization and infiltration of T cells in tumors","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2024.12.007_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1001572","article-title":"Toxicity of metal-based nanoparticles: challenges in the nano era","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.931759","article-title":"Nanoparticles in ocular applications and their potential toxicity","volume":"9","author":"Yang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.apsb.2024.12.007_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-019-0479-x","article-title":"Nanocomposites as biomolecules delivery agents in nanomedicine","volume":"17","author":"Bamburowicz-Klimkowska","year":"2019","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2024.12.007_bib149","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1039\/D1CS00918D","article-title":"Toxicity of metal-organic framework nanoparticles: from essential analyses to potential applications","volume":"51","author":"Ettlinger","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/17435390.2023.2186279","article-title":"Predicting the toxicity of nanoparticles using artificial intelligence tools: a systematic review","volume":"17","author":"Banaye Yazdipour","year":"2023","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.apsb.2024.12.007_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10661-021-09066-2","article-title":"Role of model organisms and nanocompounds in human health risk assessment","volume":"193","author":"Lopes","year":"2021","journal-title":"Environ Monit Assess"},{"key":"10.1016\/j.apsb.2024.12.007_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06577","article-title":"Subchronic oral toxicity evaluation of gold nanoparticles in male and female mice","volume":"7","author":"Sun","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2024.12.007_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101169","article-title":"Safety assessment of nanoparticles in food: current status and prospective","volume":"39","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib154","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.apsb.2021.09.029","article-title":"The effect of drug loading and multiple administration on the protein corona formation and brain delivery property of PEG-PLA nanoparticles","volume":"12","author":"Tang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib155","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s12094-023-03117-5","article-title":"Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety","volume":"25","author":"Li","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.apsb.2024.12.007_bib156","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/nano10040610","article-title":"Evaluation of ecotoxicology assessment methods of nanomaterials and their effects","volume":"10","author":"Boros","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib157","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2021.06.016","article-title":"Methodological needs in the quality and safety characterisation of nanotechnology-based health products: priorities for method development and standardisation","volume":"336","author":"Halamoda-Kenzaoui","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41578-020-00255-y","article-title":"Emerging materials intelligence ecosystems propelled by machine learning","volume":"6","author":"Batra","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib159","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/smll.201201492","article-title":"Biosafety and bioapplication of nanomaterials by designing protein\u2013nanoparticle interactions","volume":"9","author":"Yang","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.apsb.2024.12.007_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.612659","article-title":"Novel methods and approaches for safety evaluation of nanoparticle formulations: a focus towards in\u00a0vitro models and adverse outcome pathways","volume":"12","author":"Tirumala","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2024.12.007_bib161","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/pharmaceutics14020247","article-title":"The Hitchhiker's guide to human therapeutic nanoparticle development","volume":"14","author":"Ramos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib162","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"de Almeida","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib163","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2183815","article-title":"A detailed insight of the tumor targeting using nanocarrier drug delivery system","volume":"30","author":"Batool","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2024.12.007_bib164","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","article-title":"Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies","volume":"320","author":"Marques","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib165","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.apsb.2024.04.015","article-title":"Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders","volume":"14","author":"Arjunan","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib166","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/molecules28135145","article-title":"Cancer nanomedicine: emerging strategies and therapeutic potentials","volume":"28","author":"Xu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2024.12.007_bib167","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/jnt4030014","article-title":"Recent advancement of bio-inspired nanoparticles in cancer theragnostic","volume":"4","author":"Tripathi","year":"2023","journal-title":"J Nanotheranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib168","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib169","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actbio.2019.09.009","article-title":"Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: a review","volume":"101","author":"Thakkar","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2024.12.007_bib170","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200359p","article-title":"Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy","volume":"114","author":"Yao","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib171","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.apsb.2019.12.014","article-title":"Self-assembled natural phytochemicals for synergistically antibacterial application from the enlightenment of traditional Chinese medicine combination","volume":"10","author":"Tian","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib172","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/nano11092318","article-title":"The recent progress on silver nanoparticles: synthesis and electronic applications","volume":"11","author":"Bouafia","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib173","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1039\/D1NR08144F","article-title":"Green approaches for the synthesis of metal and metal oxide nanoparticles using microbial and plant extracts","volume":"14","author":"Jeevanandam","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2024.12.007_bib174","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.addr.2018.04.004","article-title":"Transforming nanomedicine manufacturing toward Quality by Design and microfluidics","volume":"128","author":"Colombo","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib175","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2024.12.007_bib176","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41578-023-00581-x","article-title":"New opportunities and old challenges in the clinical translation of nanotheranostics","volume":"8","author":"Gawne","year":"2023","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib177","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines\u2014lessons learned from successes and failures","volume":"52","author":"He","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib178","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2217\/nnm-2017-0039","article-title":"Challenges associated and approaches for successful translation of nanomedicines into commercial products","volume":"12","author":"Agrahari","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib179","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2019.09.017","article-title":"Clinical applications of nanomedicine in cancer therapy","volume":"25","author":"Norouzi","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-019-0068-3","article-title":"Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles","volume":"4","author":"Singh","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib181","first-page":"203","article-title":"Clinical progress of nanomedicine-based RNA therapies","volume":"12","author":"Lim","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib182","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/898146","article-title":"Clinical trials with pegylated liposomal doxorubicin in the treatment of ovarian cancer","volume":"2013","author":"Pisano","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.apsb.2024.12.007_bib183","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/14737140.7.7.919","article-title":"Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy","volume":"7","author":"Henderson","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib184","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.12.007_bib185","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.2147\/OTT.S105587","article-title":"Onivyde for the therapy of multiple solid tumors","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.apsb.2024.12.007_bib186","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.accounts.9b00148","article-title":"Combining nanomedicine and immunotherapy","volume":"52","author":"Shi","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib187","article-title":"Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802244","article-title":"Emerging strategies of nanomaterial-mediated tumor radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2024.12.007_bib189","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1039\/D3TB03046F","article-title":"Radiation responsive PROTAC nanoparticles for tumor-specific proteolysis enhanced radiotherapy","volume":"12","author":"Xu","year":"2024","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2024.12.007_bib190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jconrel.2013.04.026","article-title":"Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer","volume":"171","author":"Desale","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib191","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s44222-022-00017-1","article-title":"Fluorescence image-guided tumour surgery","volume":"1","author":"Wang","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.apsb.2024.12.007_bib192","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00259-021-05545-3","article-title":"RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery","volume":"49","author":"Liu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.apsb.2024.12.007_bib193","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib194","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.envint.2017.03.001","article-title":"Strategies and knowledge gaps for improving nanomaterial biocompatibility","volume":"102","author":"Hu","year":"2017","journal-title":"Environ Int"},{"key":"10.1016\/j.apsb.2024.12.007_bib195","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.nantod.2016.06.006","article-title":"Nanomedicine and tumor heterogeneity: concept and complex reality","volume":"11","author":"Ekdawi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib196","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nano.2009.06.001","article-title":"Translational nanomedicine: status assessment and opportunities","volume":"5","author":"Murday","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib197","article-title":"Current regulatory landscape of nanomaterials and nanomedicines: a global perspective","volume":"80","author":"Ali","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2024.12.007_bib198","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jpm11010045","article-title":"The potential benefit of expedited development and approval programs in precision medicine","volume":"11","author":"Kantor","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib199","doi-asserted-by":"crossref","first-page":"47504","DOI":"10.1021\/acsomega.2c05609","article-title":"Preclinical models for Alzheimer's disease: past, present, and future approaches","volume":"7","author":"Akhtar","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.apsb.2024.12.007_bib200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.abq6851","article-title":"Data sharing and community-engaged research","volume":"378","author":"Sabatello","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2024.12.007_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2020.101814","article-title":"A multicenter random forest model for effective prognosis prediction in collaborative clinical research network","volume":"103","author":"Li","year":"2020","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/joim.13254","article-title":"Nanotechnology for modern medicine: next step towards clinical translation","volume":"290","author":"Sindhwani","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2024.12.007_bib203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1557\/s43577-021-00132-1","article-title":"Optimizing nanoparticle design and surface modification toward clinical translation","volume":"46","author":"Gessner","year":"2021","journal-title":"MRS Bull"},{"key":"10.1016\/j.apsb.2024.12.007_bib204","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.2147\/IJN.S321416","article-title":"Nanoparticle-mediated targeted drug delivery to remodel tumor microenvironment for cancer therapy","volume":"16","author":"Tang","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib205","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s12274-021-3781-5","article-title":"Nanoparticles targeting tumor-associated macrophages: a novel anti-tumor therapy","volume":"15","author":"Chen","year":"2022","journal-title":"Nano Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41565-018-0319-4","article-title":"In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment","volume":"14","author":"Chen","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2024.12.007_bib207","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.7150\/thno.47982","article-title":"Nanomedicine therapies modulating macrophage dysfunction: a potential strategy to attenuate cytokine storms in severe infections","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2024.12.007_bib208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tips.2017.10.009","article-title":"Remodeling the tumor microenvironment with emerging nanotherapeutics","volume":"39","author":"Chen","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib209","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1016\/j.apsb.2022.05.026","article-title":"Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression","volume":"12","author":"Cui","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41568-023-00567-5","article-title":"The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment","volume":"23","author":"Bartish","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.12.007_bib211","article-title":"Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors","volume":"24","author":"Kim","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib212","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41568-021-00399-1","article-title":"Artificial intelligence in cancer research, diagnosis and therapy","volume":"21","author":"Elemento","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.12.007_bib213","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001883","article-title":"Role of artificial intelligence and machine learning in nanosafety","volume":"16","author":"Winkler","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.apsb.2024.12.007_bib214","doi-asserted-by":"crossref","first-page":"19244","DOI":"10.1021\/acsnano.1c04862","article-title":"Simultaneous, single-particle measurements of size and loading give insights into the structure of drug-delivery nanoparticles","volume":"15","author":"Kamanzi","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib215","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab523","article-title":"Artificial intelligence in clinical research of cancers","volume":"23","author":"Shao","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2024.12.007_bib216","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/17435889.2024.2359355","article-title":"The role of artificial intelligence and data science in nanoparticles development: a review","volume":"19","author":"Silveira","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib217","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10549-021-06310-8","article-title":"Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer","volume":"189","author":"Kim","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.apsb.2024.12.007_bib218","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1021\/acs.jcim.1c00706","article-title":"HiDRA: hierarchical network for drug response prediction with attention","volume":"61","author":"Jin","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2024.12.007_bib219","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1538-7445.AM2022-1159","article-title":"Predicting clinical drug responses using a few-shot learning-based interpretable AI","volume":"82","author":"Park","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.12.007_bib220","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.1021\/acsnano.2c04148","article-title":"From prevention to therapy: a roadmap of nanotechnologies to stay ahead of future pandemics","volume":"16","author":"Chandra","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib221","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.2147\/IJN.S378074","article-title":"Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis","volume":"17","author":"Dessale","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib222","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/nano11123330","article-title":"Novel perspectives towards RNA-based nano-theranostic approaches for cancer management","volume":"11","author":"Arshad","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2024.12.007_bib223","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1039\/C6LC00279J","article-title":"Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide\/polydopamine coating","volume":"16","author":"Zhang","year":"2016","journal-title":"Lab Chip"},{"key":"10.1016\/j.apsb.2024.12.007_bib224","doi-asserted-by":"crossref","first-page":"7744","DOI":"10.1021\/acsnano.1c01741","article-title":"Detection of single cancer cells in blood with artificially intelligent nanoarray","volume":"15","author":"Einoch-Amor","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib225","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","article-title":"Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment","volume":"15","author":"Gao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib226","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2217\/nnm-2021-0298","article-title":"Nanostructure-based surface-enhanced Raman scattering for diagnosis of cancer","volume":"16","author":"Lin","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2024.12.007_bib227","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1021\/acsnano.4c00666","article-title":"A panorama of extracellular vesicle applications: from biomarker detection to therapeutics","volume":"18","author":"Das","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.12.007_bib228","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1016\/j.apsb.2022.05.002","article-title":"Extracellular vesicles: emerging tools as therapeutic agent carriers","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib229","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.apsb.2022.07.009","article-title":"Self-therapeutic metal-based nanoparticles for treating inflammatory diseases","volume":"13","author":"Han","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib230","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.apsb.2020.12.014","article-title":"Extracellular vesicle activities regulating macrophage-and tissue-mediated injury and repair responses","volume":"11","author":"Hu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib231","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1016\/j.apsb.2024.06.010","article-title":"Recent advances to address challenges in extracellular vesicle-based applications for lung cancer","volume":"14","author":"Huang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib232","article-title":"Nanoparticle-based nanomedicines to promote cancer immunotherapy: recent advances and future directions","volume":"15","author":"Liu","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.apsb.2024.12.007_bib233","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.addr.2012.06.012","article-title":"Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy","volume":"64","author":"Ryu","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2024.12.007_bib234","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s43094-023-00569-y","article-title":"Pharmacokinetics of nanoparticles: current knowledge, future directions and its implications in drug delivery","volume":"9","author":"Haripriyaa","year":"2023","journal-title":"Futur J Pharm Sci"},{"key":"10.1016\/j.apsb.2024.12.007_bib235","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jconrel.2014.04.027","article-title":"Theranostic nanoparticles for future personalized medicine","volume":"190","author":"Ryu","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.12.007_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114135","article-title":"Nanoparticle-mediated therapeutic management in cholangiocarcinoma drug targeting: current progress and future prospects","volume":"158","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2024.12.007_bib237","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s44222-023-00026-8","article-title":"CRISPR-based assays for low-resource settings","volume":"1","author":"Huang","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.apsb.2024.12.007_bib238","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1567201813666160713121122","article-title":"Nanoparticles for cancer targeting: current and future directions","volume":"13","author":"Swain","year":"2016","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.apsb.2024.12.007_bib239","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.apsb.2021.03.007","article-title":"Effect of physicochemical properties on in\u00a0vivo fate of nanoparticle-based cancer immunotherapies","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.12.007_bib240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/pharmaceutics14020435","article-title":"Recent developments in metallic nanomaterials for cancer therapy, diagnosing and imaging applications","volume":"14","author":"P\u0103duraru","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2024.12.007_bib241","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s11671-021-03489-z","article-title":"Nanoparticles: a new approach to upgrade cancer diagnosis and treatment","volume":"16","author":"Yu","year":"2021","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2024.12.007_bib242","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2024.12.007_bib243","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nantod.2019.01.002","article-title":"The rise of private\u2013public collaboration in nanotechnology","volume":"25","author":"Zingg","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2024.12.007_bib244","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat Nanotechnol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524004647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:19:02Z","timestamp":1740651542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524004647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":244,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211383524004647"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.12.007","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}